Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regulation of lipid and lipoprotein metabolism by PPAR activators.
Gervois P, Torra IP, Fruchart JC, Staels B. Gervois P, et al. Clin Chem Lab Med. 2000 Jan;38(1):3-11. doi: 10.1515/CCLM.2000.002. Clin Chem Lab Med. 2000. PMID: 10774955 Review.
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M, Gervois PP, Poulain P, Derudas B, Peters JM, Gonzalez FJ, Princen HM, Kooistra T, Staels B. Kockx M, et al. Among authors: gervois pp. Blood. 1999 May 1;93(9):2991-8. Blood. 1999. PMID: 10216095
PPARα as a therapeutic target in inflammation-associated diseases.
Gervois P, Mansouri RM. Gervois P, et al. Expert Opin Ther Targets. 2012 Nov;16(11):1113-25. doi: 10.1517/14728222.2012.715633. Epub 2012 Aug 27. Expert Opin Ther Targets. 2012. PMID: 22925108 Review.
Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages.
Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G. Fontaine C, et al. Among authors: gervois p. Circ Res. 2007 Jul 6;101(1):40-9. doi: 10.1161/CIRCRESAHA.106.135814. Epub 2007 May 31. Circ Res. 2007. PMID: 17540978
Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response.
Mansouri RM, Baugé E, Staels B, Gervois P. Mansouri RM, et al. Among authors: gervois p. Endocrinology. 2008 Jun;149(6):3215-23. doi: 10.1210/en.2007-1339. Epub 2008 Mar 6. Endocrinology. 2008. PMID: 18325987
Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators.
Vu-Dac N, Gervois P, Jakel H, Nowak M, Bauge E, Dehondt H, Staels B, Pennacchio LA, Rubin EM, Fruchart-Najib J, Fruchart JC. Vu-Dac N, et al. Among authors: gervois p. J Biol Chem. 2003 May 16;278(20):17982-5. doi: 10.1074/jbc.M212191200. Epub 2003 Mar 12. J Biol Chem. 2003. PMID: 12637506
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation.
Fontaine C, Dubois G, Duguay Y, Helledie T, Vu-Dac N, Gervois P, Soncin F, Mandrup S, Fruchart JC, Fruchart-Najib J, Staels B. Fontaine C, et al. Among authors: gervois p. J Biol Chem. 2003 Sep 26;278(39):37672-80. doi: 10.1074/jbc.M304664200. Epub 2003 Jun 23. J Biol Chem. 2003. PMID: 12821652
Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.
Mansouri RM, Baugé E, Gervois P, Fruchart-Najib J, Fiévet C, Staels B, Fruchart JC. Mansouri RM, et al. Among authors: gervois p. Circ Res. 2008 Aug 29;103(5):450-3. doi: 10.1161/CIRCRESAHA.108.179861. Epub 2008 Jul 24. Circ Res. 2008. PMID: 18658049
Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B. Zambon A, et al. Among authors: gervois p. Arterioscler Thromb Vasc Biol. 2006 May;26(5):977-86. doi: 10.1161/01.ATV.0000204327.96431.9a. Epub 2006 Jan 19. Arterioscler Thromb Vasc Biol. 2006. PMID: 16424352 Review.
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P, Fruchart JC, Staels B. Gervois P, et al. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17237841 Review.
53 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page